SWOT Analysis for Biocon Ltd.

MACD Crossover Above Signal Line
Price crossing above SMA20 today, and greater than SMA5
Strong Annual EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
High Volume, High Gain
Stocks in uptrend most likely to cross above SMA-200 soon
MACD crossed above signal line previous end of day
Top Gainers
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

High Volume, High Gain

Stocks in uptrend most likely to cross above SMA-200 soon

MACD crossed above signal line previous end of day

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Major fall in TTM Net Profit
Fall in Quarterly Revenue and Net Profit (YoY)
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Major fall in TTM Net Profit

Fall in Quarterly Revenue and Net Profit (YoY)

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Companies with Upcoming Results
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months

Companies with Upcoming Results

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Broker downgrades in price or recommendation in the past one month

Broker downgrades in price or recommendation in the past one month

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Biocon Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Biocon Ltd. has 19 Strengths, 9 Weaknesses, 4 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

MACD Crossover Above Signal Line

Price crossing above SMA20 today, and greater than SMA5

Strong Annual EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Turnaround companies- loss to profit QoQ

Growth in Net Profit with increasing Profit Margin (QoQ)

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

High Volume, High Gain

Stocks in uptrend most likely to cross above SMA-200 soon

MACD crossed above signal line previous end of day

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Major fall in TTM Net Profit

Fall in Quarterly Revenue and Net Profit (YoY)

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Companies with Upcoming Results

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Broker downgrades in price or recommendation in the past one month

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks